Login

UNDEFINED: wu-login-soft-user-unknown

 
Current issue
About the journal
Issue archive
Editorial Board
Redaction
Subscription
For authors and reviewers
Contact us
A diabetic patient with peripheral arterial disease

A diabetic patient with peripheral arterial disease

Diabetes mellitus and peripheral arterial disease frequently occur particularly at older age. Their simultaneous course presents a significant risk of vascular complications...

Full article   Forum Diabetologicum Issue: 1/2018

Specialization: Diabetology Internal medicine Endocrinology
Complex management of diabetic patients with lower extremity peripheral arterial disease

Complex management of diabetic patients with lower extremity peripheral arterial disease

Extremitovascular arterial ischemic disease (lower extremity peripheral arterial disease – PAD) is an important manifestation of systemic atherosclerosis and other arterial...

Full article   Forum Diabetologicum Issue: 1/2018

Specialization: Endocrinology Diabetology Internal medicine
PCSK9 inhibitors and the role of evolocumab in the therapy for patients with hyperlipoproteinemia

PCSK9 inhibitors and the role of evolocumab in the therapy for patients with hyperlipoproteinemia

Relationship between LDL-cholesterol levels and cardiovascular risk is clear now­adays in the evidence-based medicine. Similarly also in the place of statins as the first line...

Full article   Forum Diabetologicum Issue: 1/2018

Specialization: Endocrinology Diabetology Internal medicine
Vildagliptin: experience and prospects

Vildagliptin: experience and prospects

Vildagliptin is one of the modern antidiabetic drugs from the incretin group. It is a dipeptidyl peptidase-4 (DPP-4i) inhibitor, whose effectiveness and safety (including...

Full article   Forum Diabetologicum Issue: 1/2018

Specialization: Diabetology Internal medicine Endocrinology
A consensual therapeutic recommendation for type 2 diabetes mellitus by the Slovak Diabetes Society (2018)

A consensual therapeutic recommendation for type 2 diabetes mellitus by the Slovak Diabetes Society (2018)

Type 2 diabetes mellitus is a heterogeneous medical condition involving multiple pathophysiological mechanisms. Its successful treatment requires an individualized approach and...

Full article   Forum Diabetologicum Issue: 1/2018

Specialization: Endocrinology Internal medicine Diabetology
Comprehensive approach in the management of patients with diabesity

Comprehensive approach in the management of patients with diabesity

Obesity is currently a global epidemic (pandemic) and the most common metabolic disorder affecting not only adults but also children and adolescents worldwide. Together with the...

Full article   Forum Diabetologicum Issue: 1/2018

Specialization: Internal medicine Endocrinology Diabetology
Management of the patient with diabetes mellitus and hypertension

Management of the patient with diabetes mellitus and hypertension

Diabetes mellitus and hypertension represent important comorbidities, contribut­ing to the high mortality in this patient group. Therefore they are also called as the lethal...

Full article   Forum Diabetologicum Issue: 1/2018

Specialization: Internal medicine Endocrinology Diabetology
Atrial fibrilation and diabetes mellitus

Atrial fibrilation and diabetes mellitus

Atrial fibrillation and diabetes mellitus are both highly prevalent and global public health issues. Importantly patients with diabetes mellitus are at increased risk for stroke...

Full article   Forum Diabetologicum Issue: 3/2017

Specialization: Diabetology Endocrinology Internal medicine
Pharmacological management of diabetic dyslipidaemia

Pharmacological management of diabetic dyslipidaemia

Cardiovascular diseases are extremely common in type 2 diabetics. This is due to the presence of characteristic atherogenic dyslipidemia, which significantly contributes to...

Full article   Forum Diabetologicum Issue: 3/2017

Specialization: Internal medicine Endocrinology Diabetology
Fourier Study: Has it brought little or a lot of good? Or has it just failed to reach exaggerated expectations?

Fourier Study: Has it brought little or a lot of good? Or has it just failed to reach exaggerated expectations?

The drugs of a novel class of hypolipidemic agents, PCSK9-inhibitors, are now approved for clinical use. In many EU countries, including Slovakia, these drugs are also available...

Full article   Forum Diabetologicum Issue: 3/2017

Specialization: Diabetology Endocrinology Internal medicine
 

Most read